Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake

By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...
Dealbreaker on MSN

Pfizer pockets $1.9B by offloading stake in HIV drugs company majority owned by GSK

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.
Fierce Pharma

Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...
pharmaphorum

ViiV ownership shifts as Pfizer sells its stake

Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's ...